Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
PTC Therapeutics Inc (NASDAQ: PTCT) closed the day trading at $46.60 down -8.56% from the previous closing price of $50.96. In other words, the price has decreased by -$8.56 from its previous closing price. On the day, 2.88 million shares were traded. PTCT stock price reached its highest trading level at $51.43 during the session, while it also had its lowest trading level at $46.37.
Ratios:
For a better understanding of PTCT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.31 and its Current Ratio is at 2.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on March 11, 2025, Upgraded its rating to Neutral and sets its target price to $55 from $41 previously.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Perform rating and target price of $55.
Morgan Stanley Upgraded its Equal-Weight to Overweight on December 13, 2024, whereas the target price for the stock was revised from $45 to $67.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 17 ’25 when Pauwels Eric sold 6,762 shares for $56.80 per share. The transaction valued at 384,067 led to the insider holds 72,640 shares of the business.
Pauwels Eric sold 4,458 shares of PTCT for $246,037 on Mar 14 ’25. The CHIEF BUSINESS OFFICER now owns 79,402 shares after completing the transaction at $55.19 per share. On Mar 13 ’25, another insider, Okey Stephanie, who serves as the Director of the company, sold 5,000 shares for $54.00 each. As a result, the insider received 270,000 and left with 8,867 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTCT now has a Market Capitalization of 3675313920 and an Enterprise Value of 4992929792. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.56. Its current Enterprise Value per Revenue stands at 6.189 whereas that against EBITDA is -70.24.
Stock Price History:
The Beta on a monthly basis for PTCT is 0.58, which has changed by 0.6068965 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, PTCT has reached a high of $58.38, while it has fallen to a 52-week low of $24.00. The 50-Day Moving Average of the stock is -8.76%, while the 200-Day Moving Average is calculated to be 12.19%.
Shares Statistics:
Over the past 3-months, PTCT traded about 775.01K shares per day on average, while over the past 10 days, PTCT traded about 1080920 shares per day. A total of 77.70M shares are outstanding, with a floating share count of 76.82M. Insiders hold about 2.60% of the company’s shares, while institutions hold 97.64% stake in the company. Shares short for PTCT as of 1741910400 were 4302958 with a Short Ratio of 5.55, compared to 1739491200 on 3696224. Therefore, it implies a Short% of Shares Outstanding of 4302958 and a Short% of Float of 8.38.
